.5], 500 mM NaCl, 300 mM imidazole, 1% NP-40, 1X protease inhibitor cocktail) with gentle rotation at 4 o C for 30 min. Proteins were subjected to another round of purification using Superdex 200 gel-filtration chromatography. Purified protein samples were dialyzed to remove traces of imidazole using dialysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10% glycerol). Protein concentrations were measured using BCA assay and proteins were flash frozen in liquid nitrogen and stored at -80 o C. A-B, K-H physically interacts with Ku. Recombinant Ku70-Ku86 (Ku) complex was a generous gift from David Chen laboratory at UTSW (2,3) and K-H proteins was purified in our laboratory. SDS-PAGE and Western blot analyses are presented. Lane 1 and 2 represent protein marker (in kDa) and purified proteins, respectively. Co-IP experiments were then conducted using these proteins and K-H polyclonal antibodies. All pull-down studies were performed as described in 'Materials and Methods' except that purified proteins (Ku and K-H, 5 µg each) were used instead of cell lysates. Although some background Ku and K-H was noted with IgG pull-downs but the co-IP of Ku with K-H antibody was considerably enriched (~2-4 fold) over the control. These data support a direct interaction between Ku and K-H, and are consistent with prior evidence showing that K-H and Ku form higher order complexes (this study (Fig. 1) and (4) ) that might regulate Ku function, such as regulating basal level Apaf1 activities. C-D, K-H loss stimulates a 'leaky' Apaf1 expression-caspase-3 activation-MLH1/PMS2 degradation. Since evidence in Fig. S4B supports a direct interaction with Ku, and other evidence also supports possible interaction with Ku (heterodimer of Ku86/Ku70) ( Fig.1 and (4) ), we favor a hypothesis whereby K-H functions to increase the efficiency of Ku complex binding to a specific regulatory region (gray box) within the Apaf1 promoter (white box). Prior data demonstrated that Ku binding within this region can inhibit Apaf1 promoter activity and Apaf1 protein expression, resulting in suppression of caspase-3 activation (5). Data presented here are consistent with the hypothesis that the direct interaction of K-H and Ku (B) is involved in the formation of a K-H-Ku complex that actively suppresses Apaf1 expression, and works to prevent the activation of caspase-3 (C). Upon K-H loss (due to one copy number loss or expression knockdown), leaky promoter activity and expression of Apaf1 constitutively activates caspase-3 resulting in MLH1 and subsequently PMS2 protein degradation (D). MLH1 harbors a caspase-3 proteolytic cleavage site (6) . Degradation of MLH1 leads to concomitant loss of PMS2 (Fig. 5) resulting in a MMR defect. The MMR repair defect presented as 6-TG damage tolerance (Fig. 2) , defective G 2 cell cycle checkpoint responses (Fig. 3) , and an overall MSI+ mutator genotype (Fig. 4) . z-VAD, a pan-caspase inhibitor, prevents caspase-3 activity and restores MLH1-PMS2 expression in K-H knockdown cells (Fig. 5) . Further work is necessary to provide proof of this proposed hypothesis. 
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